Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report
Background Neuropsychiatric symptoms associated with long COVID are a growing concern. A proposed pathophysiology is increased inflammatory mediators. There is evidence that typical serotonergic antidepressants have limited efficacy in the presence of inflammation. Although ketamine has shown promis...
Salvato in:
Autori principali: | , , , , , |
---|---|
Natura: | Libro |
Pubblicazione: |
American Association of Psychiatric Pharmacists,
2023-10-01T00:00:00Z.
|
Soggetti: | |
Accesso online: | Connect to this object online. |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Accesso online
Connect to this object online.3rd Floor Main Library
Collocazione: |
A1234.567 |
---|---|
Copia 1 | Disponibile |